Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

41. A third of people with dementia have treatable vision problems

A third of people with dementia have treatable vision problems A third of people with dementia have treatable vision problems Discover Portal Discover Portal A third of people with dementia have treatable vision problems Published on 27 September 2016 doi: New data shows that around a third of people with dementia have serious vision problems, such as cataracts or short sightedness, more than the general population of that age. Levels are higher still for people with dementia in care homes (...) – about half have vision problems. Yet this study showed that many of the people with dementia and vision impairment had not received the right treatment. This often involves simple measures. For many, spectacles could have improved poor sight. A quarter had cataracts, which surgery could have corrected. Quality of life is known to improve if visual impairment is corrected. Failure to receive treatment may be due to lack of awareness amongst people with dementia and their carers about the services

2019 NIHR Dissemination Centre

42. Case managers improve outcomes for people with dementia and their carers

Case managers improve outcomes for people with dementia and their carers Case managers for people with dementia and their carers Discover Portal Discover Portal Case managers improve outcomes for people with dementia and their carers Published on 24 April 2018 doi: Using a case manager to coordinate health and social care improves the challenging behaviour of people with dementia and reduces the burden on caregivers. Quality of life of caregivers improves the most when case managers have (...) a professional background in nursing. This NIHR-funded review compared the effectiveness of standard community treatment and interventions with case managers overseeing the interventions for people living with dementia. It considered evidence from 14 trials in a number of countries, with different health systems and support. Care coordination is variable across the UK, but this is often not provided by a qualified professional, so they are not able to develop and update the care plan. Though the review did

2019 NIHR Dissemination Centre

43. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. (PubMed)

Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. There are currently no proven treatments to reduce the risk of mild cognitive impairment and dementia.To evaluate the effect of intensive blood pressure control on risk of dementia.Randomized clinical trial conducted at 102 sites in the United States and Puerto Rico among adults aged 50 years or older with hypertension but without diabetes or history of stroke. Randomization began (...) on November 8, 2010. The trial was stopped early for benefit on its primary outcome (a composite of cardiovascular events) and all-cause mortality on August 20, 2015. The final date for follow-up of cognitive outcomes was July 22, 2018.Participants were randomized to a systolic blood pressure goal of either less than 120 mm Hg (intensive treatment group; n = 4678) or less than 140 mm Hg (standard treatment group; n = 4683).The primary cognitive outcome was occurrence of adjudicated probable dementia

2019 JAMA

44. Communication training and its effects on carer and care-receiver outcomes in dementia settings: A systematic review

Communication training and its effects on carer and care-receiver outcomes in dementia settings: A systematic review To review communication interventions that aim to improve regular care interactions between people with dementia and their carers in various settings; and to examine the impact of such interventions on both carer and care-receiver outcomes.Effective communication is imperative to ensure quality of care for people living with dementia. Due to neurodegenerative changes, people (...) with dementia encounter ongoing and progressive difficulties in both understanding and expressing themselves. This in turn creates challenges for carers, which highlights the need for equipping them with necessary communication skills to respond to the specific communication needs of people with dementia.Systematic review and meta-analysis.Medline, Embase, CINAHL, ProQuest and PsycINFO databases were searched for eligible interventions with any date of the publication. Hand searching was also conducted

Full Text available with Trip Pro

2019 EvidenceUpdates

45. Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study

Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study Trazodone is increasingly prescribed for behavioural and psychological symptoms of dementia, but little is known about its risk of harm. Our objective was to describe the comparative risk of falls and fractures among older adults with dementia dispensed trazodone or atypical antipsychotics.The study cohort included adults with dementia (excluding patients (...) (weighted HR 0.91, 95% CI 0.75 to 1.11) and hip fractures (weighted HR 0.92, 95% CI 0.59 to 1.43). Use of trazodone was associated with a lower rate of mortality (weighted HR 0.75, 95% CI 0.66 to 0.85).Trazodone is not a uniformly safer alternative to atypical antipsychotics, given the similar risk of falls and fractures among older adults with dementia.© 2018 Joule Inc. or its licensors.

Full Text available with Trip Pro

2019 EvidenceUpdates

46. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. (PubMed)

Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. There are currently no proven treatments to reduce the risk of mild cognitive impairment and dementia.To evaluate the effect of intensive blood pressure control on risk of dementia.Randomized clinical trial conducted at 102 sites in the United States and Puerto Rico among adults aged 50 years or older with hypertension but without diabetes or history of stroke. Randomization began (...) on November 8, 2010. The trial was stopped early for benefit on its primary outcome (a composite of cardiovascular events) and all-cause mortality on August 20, 2015. The final date for follow-up of cognitive outcomes was July 22, 2018.Participants were randomized to a systolic blood pressure goal of either less than 120 mm Hg (intensive treatment group; n = 4678) or less than 140 mm Hg (standard treatment group; n = 4683).The primary cognitive outcome was occurrence of adjudicated probable dementia

2019 JAMA

47. France has delisted anti-dementia agents

France has delisted anti-dementia agents MED CHECK - TIP December 2018/ Vol.4 No.12 · Page 29 -The Informed Prescriber C N o 12 M ED HECK D e ce m b e r 2 0 1 8 Dying Cochrane: Could it be resuscitated? Herpes zoster subunit vaccine Shingrix: Baloxavir (Xofluza®) for Influenza: No Value No difference from Tamiflu in efficacy, and suppresses immunity Cochrane review on HPV vaccine should be revised: Due to missing trials, adjuvant toxicity, mortality and healthy user bias Editorial Dying

2019 Med Check - The Informed Prescriber

48. Assessment tools used to screen for dementia in African adults in hospital and community settings, a mixed methods review

Assessment tools used to screen for dementia in African adults in hospital and community settings, a mixed methods review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

49. Are counselling interventions effective for people with dementia and their families?

Are counselling interventions effective for people with dementia and their families? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

50. Antihypertensive medication classes and the risk of dementia: a network meta-analysis

Antihypertensive medication classes and the risk of dementia: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

51. Changes in handwriting, speech and reading abilities as indicators for early detection of cognitive impairment and dementia: a systematic review

Changes in handwriting, speech and reading abilities as indicators for early detection of cognitive impairment and dementia: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

52. The involvement of people with dementia in advocacy: a systematic narrative review

The involvement of people with dementia in advocacy: a systematic narrative review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

53. The incidence trend of dementia over the past decades: a systematic review and meta-analysis

The incidence trend of dementia over the past decades: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

54. What are dementia caregivers experiences of grief and bereavement? A qualitative systematic review.

What are dementia caregivers experiences of grief and bereavement? A qualitative systematic review. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

55. Treatment of hypertension to prevent the development of dementia and cognitive decline

Treatment of hypertension to prevent the development of dementia and cognitive decline Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

56. The impact of dance and movement on learning, health, wellbeing and quality of life of older adults living with or without dementia and/or Parkinson's in the community: a systematic review protocol

The impact of dance and movement on learning, health, wellbeing and quality of life of older adults living with or without dementia and/or Parkinson's in the community: a systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

57. The risk of incident dementia from mild cognitive impairment (MCI) in Low and Middle income countries (LMICs): a systematic review and meta-analysis

The risk of incident dementia from mild cognitive impairment (MCI) in Low and Middle income countries (LMICs): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

58. Risk for dementia in lithium treated bipolar disorder patients: a systematic review and meta-analysis

Risk for dementia in lithium treated bipolar disorder patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

59. Respiratory disease and lower pulmonary function as risk factors for subsequent dementia: a systematic review with meta-analysis

Respiratory disease and lower pulmonary function as risk factors for subsequent dementia: a systematic review with meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

60. Racial / ethnic differences in Alzheimer's disease and dementia risk in the United States: a systematic review and meta-analysis

Racial / ethnic differences in Alzheimer's disease and dementia risk in the United States: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO